Inventor · disambiguated record
Nikhil C. Munshi
Also filed as: MUNSHI NIKHIL · MUNSHI NIKHIL C
5 granted patents·8 pending applications·12 citations·filing 2001–2022
72Inventor score
Top patents by PatentIndex Score
13 records- 0185US9950047B2XBP1, CD138, and CS1 peptides, pharmaceutical compositions that include the peptides, and methods of using such peptides and compositionsDANA FARBER CANCER INST INC·Filed 2013·Granted Apr 24, 2018·9 cites·46 claims
- 0280US11517591B2Immunogenic peptides specific to BCMA and TACI antigensDANA FARBER CANCER INST INC·Filed 2018·Granted Dec 6, 2022·1 cites·38 claims
- 0377US9096681B2XBP1, CD138, and CS1 peptidesMUNSHI NIKHIL C·Filed 2009·Granted Aug 4, 2015·2 cites·11 claims
- 0468US2023248769A1Immunogenic peptides specific to bcma and taci antigens for treatment of cancerDANA FARBER CANCER INST INC·Filed 2022·Application pending·0 cites
- 0566US2022031821A1Xbp1, cd138, and cs1 peptidesDANA FARBER CANCER INST INC·Filed 2021·Application pending·0 cites
- 0664US2021170004A1Xbp1, cd138, and cs1 peptides, pharmaceutical compositions that include the peptides, and methods of using such peptides and compositionsDANA FARBER CANCER INST INC·Filed 2021·Application pending·0 cites
- 0764US2024352462A1Antisense inhibitors of mir17hg pre-rna as therapeutic agents in cancerDANA FARBER CANCER INST INC·Filed 2022·Application pending·0 cites
- 0861US2025066738A1Induced pluripotent stem cells (ipsc), t-cell compositions and methods of useDANA FARBER CANCER INST INC·Filed 2022·Application pending·0 cites
- 0959US11083783B2XBP1, CD138, and CS1 peptidesDANA FARBER CANCER INST INC·Filed 2015·Granted Aug 10, 2021·0 cites·24 claims
- 1052US12448429B2T cell receptors specific to b-cell maturation antigen for treatment of cancerDANA FARBER CANCER INST INC·Filed 2020·Granted Oct 21, 2025·0 cites·11 claims
- 1150US2018133297A1Xbp1, cd138, and cs1 peptides, pharmaceutical compositions that include the peptides, and methods of using such peptides and compositionsDANA FARBER CANCER INST INC·Filed 2017·Application pending·0 cites
- 1243US2004101836A1Compositions, methods, apparatus and products comprising a stathmin/oncoprotein 18 sequence for detecting and treating cancerFiled 2001·Application pending·0 cites
- 1339US2009068210A1Immunotherapy for hematological malignanciesMUNSHI NIKHIL C·Filed 2008·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →